Table 2.
Parameters | Saline | wt CVB3 | Mt 10 | Mt 10 + wt CVB3 |
---|---|---|---|---|
Heart | ||||
Incidence | 0/9 (0.0) | 12/18 (66.7) | 0/16 (0.0) | 0/17 (0.0) |
Mortality | 0/9 (0.0) | 9/18 (50) | 0/16 (0.0) | 0/17 (0.0) |
Myocardial lesions | 0.0 (0.0)a | 34.5 ± 13.3 | 0.0 (0.0)a | 0.0 (0.0)a |
Pancreas | ||||
Incidence | 0 (0.0) | 16/18 (88.9) | 1/16 (6.2) | 0 (0.0) |
Atrophy | 0 (0.0)a | 16/18 (88.9) | 1/16 (6.2)a | 0 (0.0)a |
Inflammation | 0 (0.0)a | 16/18 (88.9) | 0/16 (0.0)a | 0 (0.0)a |
Necrosis | 0 (0.0) | 0/18 (0.0) | 0/16 (0.0) | 0 (0.0) |
Mineralization | 0 (0.0) | 0/18 (0.0) | 0/16 (0.0) | 0 (0.0) |
() Indicates percentages.
aDenotes significant differences in comparison with wt CVB3 group (p < 0.0001).